Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system

Human Gene Therapy

Volumn 12, Issue 7, 2001, Pages 847-857

  Pandya, S ^a   Boris Lawrie, K ^b   Leung, N J ^c   Akkina, R ^d   Planelles, V ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Department of Environmental and Radiological Health Sciences   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APHIDICOLIN; NEF PROTEIN; PROTEIN; PROTEIN VPX; REV PROTEIN; UNCLASSIFIED DRUG; VIF PROTEIN; VIRUS VECTOR; VPR PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; PLASMID; SIMIAN IMMUNODEFICIENCY VIRUS; VIRION;

EID: 0034927318     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303401750148847     Document Type: Article

References (62)

1. High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G
2. Lentiviral vectors - The promise of gene therapy within reach?
3. Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: A new approach to gene therapy of HIV-infection
4. Human immunodeficiency virus type 2 lentivirus vectors for gene transfer: Expression and potential for helper virus-free packaging
5. Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8
6. Genetically simpler bovine leukemia virus derivatives can replicate independently of Tax and Rex
7. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent
8. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer efficient gene transfer into mammalian and nonmammalian cells
9. The 5′ RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeficiency virus Rev/RRE-independent Gag production
10. Vpr of simian immunodeficiency virus of African green monkeys is required for replication in macaque macrophages and lymphocytes
11. Lentiviral-mediated gene transfer into human lymphocytes: Role of HIV-1 accessory proteins
12. Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression
13. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
14. Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery system
15. Identification of highly attenuated mutants of simian immunodeficiency virus
16. Lack of competition results in efficient packaging of heterologous murine retroviral RNAs and reticuloendotheliosis virus encapsidation-minus RNAs by the reticuloendotheliosis virus helper cell line
17. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM)
18. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences
19. HIV-1: Fifteen proteins and an RNA
20. The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages
21. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells
22. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
23. Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: A possible role for the p2 domain of Gag in RNA encapsidation
24. Importance of the nef gene for maintenance of high viral load and for development of AIDS
25. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1
26. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene
27. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
28. Packaging system for rapid production of murine leukemia virus vectors with variable tropism
29. Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: Novel level of gene regulation
30. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA
31. Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells
32. Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV
33. Improved titers of HIV-based lentiviral vectors using the SRV-1 constitutive transport element
34. Stable gene transfer to the nervous system using a non-primate lentiviral vector
35. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells
36. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
37. Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA
38. Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes
39. The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway
40. Vpr-induced cell cycle arrest is conserved among primate lentiviruses
41. Development of HIV vectors for anti-HIV gene therapy
42. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors
43. HIV type 1 Tat protein induces apoptosis and death in Jurkat cells
44. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus
45. Simian immunodefeciency virus vectors: Replication and pseudotyping
46. Simian immunodeficiency virus RNA is efficiently encapsulated by human immunodeficiency virus type 1 particles
47. Rev/RRE-independent Mason-Pfizer monkey virus constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay
48. The 5′ RNA terminus of spleen necrosis virus stimulates translation of nonviral mRNA
49. Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus
50. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression
51. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein
52. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines
53. Replication of a macrophage-tropic strain of human immunodeficiency virus type 1 (HIV-1) in a hybrid cell line, CEMx174, suggests that cellular accessory molecules are required for HIV-1 entry
54. Evolution of the primate lentiviruses: Evidence from vpx vpr
55. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells
56. The nef gene of simian immunodeficiency virus SIVmac1A11
57. Lentivirus vectors using human and simian immunodeficiency virus elements
58. HIV-1 genome nuclear import is mediated by a central DNA flap
59. Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes
60. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
61. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery
62. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors